Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1E | P28566 | 3/20 | 0.51 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.47 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22188704 | 1.00 | HTR1E (0.51) | HTR1ES1PR3MEN1KMT2ALMNA | |
| SCHEMBL5049598 | 0.92 | HTR1E (0.57) | HTR1ES1PR3MEN1KMT2ALMNA | |
| SCHEMBL4866289 | 0.92 | HTR1E (0.61) | HTR1ES1PR3MEN1KMT2ALMNA | |
| SCHEMBL14453320 | 0.91 | MEN1 (0.59) | HTR1ES1PR3MEN1KMT2ALMNA | |
| Hydrochloric Acid SCHEMBL5051899 | 0.91 | HTR1E (0.59) | HTR1ES1PR3MEN1KMT2ALMNA | |
| SCHEMBL3639348 | 0.91 | MEN1 (0.59) | HTR1ES1PR3MEN1KMT2ALMNA | |
| SCHEMBL14453324 | 0.91 | MEN1 (0.59) | HTR1ES1PR3MEN1KMT2ALMNA | |
| SCHEMBL5051927 | 0.91 | MEN1 (0.59) | HTR1ES1PR3MEN1KMT2ALMNA | |
| SCHEMBL28171776 | 0.90 | KCNH2 (0.44) | HTR1ES1PR3MEN1KMT2ALMNA | |
| Water SCHEMBL28154809 | 0.89 | MEN1 (0.58) | HTR1ES1PR3MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020244968-A1 | FUNGICIDAL N-(PYRID-3-YL)CARBOXAMIDES | BASF SE (DE) | 2020-12-10 | — | — | WO | disclosed |
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRUENENTHAL GMBH (DE) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRM1, GRIN1, GRM2 | HTR1E 234/4885S1PR3 2365/4885MEN1 4274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.